Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov;53(6):603-607.
doi: 10.1007/s10384-009-0743-y. Epub 2009 Dec 18.

Initial temporal field defect in Leber hereditary optic neuropathy

Affiliations

Initial temporal field defect in Leber hereditary optic neuropathy

Masato Wakakura et al. Jpn J Ophthalmol. 2009 Nov.

Abstract

Purpose: To determine the site of the initial field defect in patients with Leber hereditary optic neuropathy (LHON).

Methods: We studied nine eyes of nine consecutive LHON patients with the 11778 mitochondrial DNA mutation who had no visual loss (four eyes) or only minimal visual loss (five eyes). When unilateral visual loss was observed, Humphrey field analysis (HFA) (HFA 30-2 program and sometimes the HFA 10-2 program) was immediately and repeatedly performed on the better eye.

Results: For the 12 centralmost points in the visual field, a loss of sensitivity (P<0.02) was initially found in the upper temporal field of nine eyes and in the lower temporal field of three eyes. These results indicate that it was possible to detect the initial site of sensitivity loss in the centralmost temporal test points in all nine cases. The HFA 10-2 program confirmed the sensitivity loss in the temporal field in two cases.

Conclusions: The centralmost temporal visual field appears to be the most susceptible site in eyes of LHON patients. This suggests that the most susceptible cells during the early stages of LHON are the retinal ganglion cells located in the corresponding region of the retina.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Jpn J Ophthalmol. 2002 Nov-Dec;46(6):660-7 - PubMed
    1. Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2528-34 - PubMed
    1. Graefes Arch Clin Exp Ophthalmol. 2005 Nov;243(11):1175-9 - PubMed
    1. Am J Ophthalmol. 1991 Jun 15;111(6):750-62 - PubMed
    1. Am J Ophthalmol. 2006 Jun;141(6):1061-1067 - PubMed

LinkOut - more resources